Literature DB >> 21087664

BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.

Yunzhe Lu1, Tao Kang, Yanfen Hu.   

Abstract

Germline mutations in BRCA1 predispose women to early onset of breast and ovarian cancers. Findings from previous studies support the notion that the tissue- and gender-specific tumor suppression function of BRCA1 is associated with its role in negative regulation of aromatase expression, the rate-limiting step in estrogen biosynthesis. The molecular mechanism of BRCA1 in regulating aromatase promoter activity remains to be elucidated. In this study, we demonstrate that, in an ovarian granulosa cell line KGN, steroidogenic factor 1 (SF-1) is required for aromatase PII promoter basal activity as well as the elevated aromatase expression mediated by BRCA1 knockdown. Furthermore, BRCA1 in KGN cells exists mainly as a heterodimer with BARD1. We provide evidence that the BRCA1/BARD1 complex interacts with SF-1 both in vivo and in vitro. However, the intrinsic ubiquitin E3 ligase activity of BRCA1/BARD1 does not appear to contribute to ubiquitynation of SF-1. We propose that the interaction between SF-1 and BRCA1/BARD1 may recruit BRCA1/BARD1 complex to the aromatase PII promoter for BRCA1/BARD1-mediate transcriptional repression.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087664      PMCID: PMC3032352          DOI: 10.1016/j.jsbmb.2010.11.006

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  33 in total

1.  BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.

Authors:  Meiling Lu; Dong Chen; Zhihong Lin; Scott Reierstad; Amy M Trauernicht; Thomas G Boyer; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

2.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

3.  Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.

Authors:  Yanfen Hu; Sagar Ghosh; Asma Amleh; Wei Yue; Yunzhe Lu; Adam Katz; Rong Li
Journal:  Oncogene       Date:  2005-12-15       Impact factor: 9.867

4.  Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.

Authors:  Yunzhe Lu; Asma Amleh; Jianlong Sun; Xuan Jin; Shaun D McCullough; Richard Baer; Daming Ren; Rong Li; Yanfen Hu
Journal:  Mol Endocrinol       Date:  2006-12-21

5.  Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.

Authors:  Dong Chen; Scott Reierstad; Zhihong Lin; Meiling Lu; Chris Brooks; Newton Li; Joy Innes; Serdar E Bulun
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary.

Authors:  Allison E Falender; Rainer Lanz; Daniel Malenfant; Luc Belanger; JoAnne S Richards
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

Review 7.  Mechanisms in the regulation of aromatase in developing ovary and placenta.

Authors:  Carole R Mendelson; Amrita Kamat
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-21       Impact factor: 4.292

8.  Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1).

Authors:  Wei-Yi Chen; Jui-Hsia Weng; Chen-Che Huang; Bon-Chu Chung
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

Review 9.  Aromatase expression in the ovary: hormonal and molecular regulation.

Authors:  Carlos Stocco
Journal:  Steroids       Date:  2008-02-01       Impact factor: 2.668

10.  EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.

Authors:  Kotha Subbaramaiah; Clifford Hudis; Sung-Hee Chang; Timothy Hla; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2007-12-14       Impact factor: 5.157

View more
  2 in total

1.  CyTRANSFINDER: a Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction.

Authors:  Gianfranco Politano; Francesca Orso; Monica Raimo; Alfredo Benso; Alessandro Savino; Daniela Taverna; Stefano Di Carlo
Journal:  BMC Bioinformatics       Date:  2016-04-08       Impact factor: 3.169

2.  Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment.

Authors:  Yi Liu; Zhibin Guo; Chenlong Zhao; Xin Li; Hongyu Liu; Jun Chen
Journal:  Onco Targets Ther       Date:  2018-08-31       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.